Cardiol Historical Financial Ratios

CRDL Stock

CAD 1.93 0.10 4.93%

Cardiol Therapeutics is presently reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.38 or Days Sales Outstanding of 1.5 K will help investors to properly organize and evaluate Cardiol Therapeutics financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Cardiol Financial Ratios Analysis

Cardiol TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Cardiol Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Cardiol financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Cardiol Therapeutics history.

Cardiol Therapeutics Financial Ratios Chart

At this time, Cardiol Therapeutics' Graham Number is very stable compared to the past year. As of the 13th of December 2024, Shareholders Equity Per Share is likely to grow to 0.64, while PTB Ratio is likely to drop 2.38.

Ptb Ratio Operating Cash Flow Per Share Average Inventory Cash Per Share Net Current Asset Value

Add Fundamental

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Average Inventory

The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.

Most ratios from Cardiol Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Cardiol Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2023	2024 (projected)
Days Sales Outstanding	1.7K	1.5K
PTB Ratio	2.51	2.38

Days Sales Outstanding Ptb Ratio

Cardiol Therapeutics fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.42	1.0	-0.07	-0.21	-0.32	-0.48	0.3	0.42	1.0	-0.32	0.46	-0.49	0.19	0.47	0.14	0.45	1.0	-0.11	0.93	0.5	-0.42	0.93	-0.54	0.89	0.39
Ptb Ratio	0.42		0.42	-0.78	0.55	0.64	-0.44	0.12	1.0	0.42	0.64	0.33	-0.79	0.8	0.87	-0.29	-0.48	0.41	-0.77	0.41	0.86	-0.73	0.41	-0.77	0.5	0.32
Days Sales Outstanding	1.0	0.42		-0.07	-0.21	-0.32	-0.48	0.3	0.42	1.0	-0.32	0.46	-0.49	0.19	0.47	0.14	0.45	1.0	-0.11	0.93	0.5	-0.42	0.93	-0.54	0.89	0.39
Book Value Per Share	-0.07	-0.78	-0.07		-0.54	-0.85	0.46	-0.19	-0.78	-0.07	-0.84	0.18	0.51	-0.77	-0.5	0.04	0.42	-0.08	0.97	-0.02	-0.48	0.67	-0.02	0.71	-0.09	0.11
Free Cash Flow Yield	-0.21	0.55	-0.21	-0.54		0.64	-0.41	0.06	0.55	-0.21	0.63	-0.26	-0.5	0.21	0.47	-0.03	-0.63	-0.2	-0.59	-0.24	0.42	-0.45	-0.24	-0.54	-0.27	-0.37
Operating Cash Flow Per Share	-0.32	0.64	-0.32	-0.85	0.64		-0.09	-0.14	0.64	-0.32	1.0	-0.22	-0.23	0.75	0.34	-0.34	-0.62	-0.31	-0.74	-0.37	0.31	-0.38	-0.37	-0.35	-0.26	-0.07
Average Payables	-0.48	-0.44	-0.48	0.46	-0.41	-0.09		-0.23	-0.44	-0.48	-0.08	0.28	0.47	0.0	-0.43	-0.37	-0.02	-0.47	0.55	-0.49	-0.44	0.43	-0.49	0.85	-0.27	0.49
Capex To Depreciation	0.3	0.12	0.3	-0.19	0.06	-0.14	-0.23		0.12	0.3	-0.16	-0.07	-0.44	0.06	0.0	0.81	0.31	0.29	-0.33	0.32	-0.02	-0.76	0.32	-0.48	0.41	-0.06
Pb Ratio	0.42	1.0	0.42	-0.78	0.55	0.64	-0.44	0.12		0.42	0.64	0.33	-0.79	0.8	0.87	-0.29	-0.48	0.41	-0.77	0.41	0.86	-0.73	0.41	-0.77	0.5	0.32
Ev To Sales	1.0	0.42	1.0	-0.07	-0.21	-0.32	-0.48	0.3	0.42		-0.32	0.46	-0.49	0.19	0.47	0.14	0.45	1.0	-0.11	0.93	0.5	-0.42	0.93	-0.54	0.89	0.39
Free Cash Flow Per Share	-0.32	0.64	-0.32	-0.84	0.63	1.0	-0.08	-0.16	0.64	-0.32		-0.22	-0.23	0.75	0.34	-0.35	-0.62	-0.31	-0.73	-0.37	0.31	-0.37	-0.37	-0.34	-0.27	-0.07
Roic	0.46	0.33	0.46	0.18	-0.26	-0.22	0.28	-0.07	0.33	0.46	-0.22		-0.49	0.25	0.59	-0.52	-0.18	0.45	0.14	0.47	0.61	-0.13	0.47	0.07	0.65	0.9
Inventory Turnover	-0.49	-0.79	-0.49	0.51	-0.5	-0.23	0.47	-0.44	-0.79	-0.49	-0.23	-0.49		-0.41	-0.89	0.01	0.42	-0.48	0.65	-0.49	-0.87	0.8	-0.49	0.75	-0.59	-0.28
Net Income Per Share	0.19	0.8	0.19	-0.77	0.21	0.75	0.0	0.06	0.8	0.19	0.75	0.25	-0.41		0.5	-0.36	-0.32	0.19	-0.64	0.17	0.5	-0.58	0.17	-0.41	0.36	0.48
Days Of Inventory On Hand	0.47	0.87	0.47	-0.5	0.47	0.34	-0.43	0.0	0.87	0.47	0.34	0.59	-0.89	0.5		-0.41	-0.57	0.45	-0.58	0.47	1.0	-0.55	0.47	-0.63	0.53	0.39
Payables Turnover	0.14	-0.29	0.14	0.04	-0.03	-0.34	-0.37	0.81	-0.29	0.14	-0.35	-0.52	0.01	-0.36	-0.41		0.56	0.13	-0.08	0.16	-0.42	-0.36	0.16	-0.32	0.07	-0.53
Average Inventory	0.45	-0.48	0.45	0.42	-0.63	-0.62	-0.02	0.31	-0.48	0.45	-0.62	-0.18	0.42	-0.32	-0.57	0.56		0.47	0.45	0.36	-0.54	0.14	0.36	0.12	0.27	-0.04
Capex To Revenue	1.0	0.41	1.0	-0.08	-0.2	-0.31	-0.47	0.29	0.41	1.0	-0.31	0.45	-0.48	0.19	0.45	0.13	0.47		-0.1	0.9	0.49	-0.41	0.9	-0.53	0.86	0.38
Cash Per Share	-0.11	-0.77	-0.11	0.97	-0.59	-0.74	0.55	-0.33	-0.77	-0.11	-0.73	0.14	0.65	-0.64	-0.58	-0.08	0.45	-0.1		-0.08	-0.55	0.75	-0.08	0.79	-0.14	0.17
Pocfratio	0.93	0.41	0.93	-0.02	-0.24	-0.37	-0.49	0.32	0.41	0.93	-0.37	0.47	-0.49	0.17	0.47	0.16	0.36	0.9	-0.08		0.52	-0.43	1.0	-0.55	0.94	0.4
Interest Coverage	0.5	0.86	0.5	-0.48	0.42	0.31	-0.44	-0.02	0.86	0.5	0.31	0.61	-0.87	0.5	1.0	-0.42	-0.54	0.49	-0.55	0.52		-0.53	0.52	-0.63	0.57	0.41
Capex To Operating Cash Flow	-0.42	-0.73	-0.42	0.67	-0.45	-0.38	0.43	-0.76	-0.73	-0.42	-0.37	-0.13	0.8	-0.58	-0.55	-0.36	0.14	-0.41	0.75	-0.43	-0.53		-0.43	0.82	-0.55	-0.14
Pfcf Ratio	0.93	0.41	0.93	-0.02	-0.24	-0.37	-0.49	0.32	0.41	0.93	-0.37	0.47	-0.49	0.17	0.47	0.16	0.36	0.9	-0.08	1.0	0.52	-0.43		-0.55	0.94	0.4
Days Payables Outstanding	-0.54	-0.77	-0.54	0.71	-0.54	-0.35	0.85	-0.48	-0.77	-0.54	-0.34	0.07	0.75	-0.41	-0.63	-0.32	0.12	-0.53	0.79	-0.55	-0.63	0.82	-0.55		-0.48	0.17
Income Quality	0.89	0.5	0.89	-0.09	-0.27	-0.26	-0.27	0.41	0.5	0.89	-0.27	0.65	-0.59	0.36	0.53	0.07	0.27	0.86	-0.14	0.94	0.57	-0.55	0.94	-0.48		0.63
Roe	0.39	0.32	0.39	0.11	-0.37	-0.07	0.49	-0.06	0.32	0.39	-0.07	0.9	-0.28	0.48	0.39	-0.53	-0.04	0.38	0.17	0.4	0.41	-0.14	0.4	0.17	0.63

Click cells to compare fundamentals

Cardiol Therapeutics Account Relationship Matchups

Cardiol Therapeutics fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Ptb Ratio	8.06	6.25	1.32	0.83	2.51	2.38
Book Value Per Share	1.45	0.57	0.44	1.76	0.84	0.64
Free Cash Flow Yield	(0.0998)	(0.11)	(0.23)	(0.63)	(3.56E-4)	(3.74E-4)
Operating Cash Flow Per Share	(0.71)	(0.44)	(0.31)	(0.54)	(3.91E-4)	(4.1E-4)
Capex To Depreciation	2.82	0.18	0.0586	0.34	2.59E-4	2.46E-4
Pb Ratio	8.06	6.25	1.32	0.83	2.51	2.38
Free Cash Flow Per Share	(0.46)	(0.31)	(0.55)	(0.44)	(3.92E-4)	(4.11E-4)
Roic	(0.95)	(1.55)	(0.47)	(0.36)	(1.05)	(1.1)
Net Income Per Share	(0.54)	(0.69)	(0.57)	(0.18)	(0.44)	(0.46)
Payables Turnover	0.0427	268.26	129.67	0.0263	0.0237	0.0225
Cash Per Share	0.27	0.47	1.94	0.95	0.54	0.62
Pocfratio	(10.39)	(9.04)	(4.28)	(1.58)	(2.8K)	(2.7K)
Capex To Operating Cash Flow	(0.0373)	(0.00442)	(5.48E-4)	(0.002745)	(0.002554)	(0.002682)
Pfcf Ratio	(10.02)	(9.0)	(4.27)	(1.58)	(2.8K)	(2.7K)
Days Payables Outstanding	8.5K	1.36	2.81	13.9K	12.5K	13.1K
Income Quality	0.83	0.45	0.74	0.88	8.95E-4	8.5E-4
Roe	(0.95)	(1.56)	(0.32)	(0.22)	(1.0)	(1.05)
Ev To Operating Cash Flow	(9.8)	(7.53)	(0.72)	0.6	(1.4K)	(1.4K)
Pe Ratio	(8.46)	(4.02)	(4.07)	(3.74)	(2.52)	(2.65)
Return On Tangible Assets	(0.94)	(1.34)	(0.28)	(0.19)	(0.77)	(0.81)
Ev To Free Cash Flow	(9.45)	(7.49)	(0.72)	0.6	(1.4K)	(1.4K)
Earnings Yield	(0.23)	(0.12)	(0.25)	(0.27)	(0.4)	(0.42)
Intangibles To Total Assets	0.0354	0.0292	0.004316	0.004753	0.005732	0.005445
Net Debt To E B I T D A	0.5	0.68	2.18	1.93	1.25	1.03
Current Ratio	20.81	5.94	7.53	6.27	4.36	4.14
Tangible Book Value Per Share	1.41	0.55	0.43	1.76	0.83	0.63
Shareholders Equity Per Share	1.45	0.57	0.44	1.76	0.84	0.64
Capex Per Share	8.97E-4	0.0164	0.00136	2.99E-4	0.001195	1.0E-6
Graham Net Net	0.29	0.39	1.68	0.8	0.41	0.55
Enterprise Value Over E B I T D A	(8.24)	(3.39)	(0.44)	0.53	(1.3)	(1.36)
Price Earnings Ratio	(8.46)	(4.02)	(4.07)	(3.74)	(2.52)	(2.65)
Price Book Value Ratio	8.06	6.25	1.32	0.83	2.51	2.38

Pair Trading with Cardiol Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardiol Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cardiol Stock

0.86	AEMC	Alaska Energy Metals	Pair Corr
0.77	CMC	Cielo Waste Solutions Earnings Call This Week	Pair Corr

Moving against Cardiol Stock

0.81	MATE	Blockmate Ventures	Pair Corr
0.75	LQWD	LQwD FinTech Corp	Pair Corr

The ability to find closely correlated positions to Cardiol Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiol Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiol Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiol Therapeutics Class to buy it.

The correlation of Cardiol Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiol Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiol Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cardiol Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cardiol Therapeutics is a strong investment it is important to analyze Cardiol Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiol Therapeutics' future performance. For an informed investment choice regarding Cardiol Stock, refer to the following important reports:

How To Invest In Cardiol

Details

Is Cardiol Stock a good investment?

Details

What is Cardiol Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Cardiol Historical Financial Ratios

About Cardiol Financial Ratios Analysis

Cardiol Therapeutics Financial Ratios Chart

Ptb Ratio

Operating Cash Flow Per Share

Average Inventory

Cardiol Therapeutics fundamentals Correlations

Cardiol Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cardiol Therapeutics fundamentals Accounts

Pair Trading with Cardiol Therapeutics

Moving together with Cardiol Stock

Moving against Cardiol Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Days Sales Outstanding	+ 1.0	Price To Sales Ratio
Ev To Sales	+ 1.0	Price To Sales Ratio
Capex To Revenue	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 1.0	Days Sales Outstanding
Capex To Revenue	+ 1.0	Days Sales Outstanding

Days Of Inventory On Hand	- 0.89	Inventory Turnover
Interest Coverage	- 0.87	Inventory Turnover
Operating Cash Flow Per Share	- 0.85	Book Value Per Share
Free Cash Flow Per Share	- 0.84	Book Value Per Share
Inventory Turnover	- 0.79	Pb Ratio
Inventory Turnover	- 0.79	Ptb Ratio